Article

FDA Presentation Slides from AANS/CNS Drugs and Devices Committee Seminar 4.26.17

  • Drugs and Devices

Introduction to FDA’s
Division of Neurological and
Physical Medicine Devices
AANS Abbreviated Slide Deck
Coming Soon
AANS FDA Session 2018

  • Patients in the U.S. have access to high-quality, safe, and effective medical devices of public health importance first in the world.
  • The U.S. is the world’s leader in regulatory science,
    medical device innovation and manufacturing, and
    radiation-emitting product safety.
  • U.S. post-market surveillance quickly identifies
    poorly performing devices, accurately characterizes
    real-world performance, and facilitates device
    approval or clearance.
  • Devices are legally marketed in the U.S. and remain
    safe, effective, and of high-quality.
  • Consumers, patients, their caregivers, and providers
    have access to understandable science-based
    information about medical devices and use this
    information to make health care decisions.

Read full article here